 Connection
Janetta Iwanicki to Opioid-Related Disorders
This is a "connection" page, showing publications Janetta Iwanicki has written about Opioid-Related Disorders.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.053 |
|
|
|
-
Mutter R, Black J, Iwanicki J. Changes in the Street Prices of Prescription Opioids During the COVID-19 Pandemic. Psychiatr Serv. 2023 01 01; 74(1):63-65.
Score: 0.406
-
Iwanicki JL, Schwarz J, May KP, Black JC, Dart RC. Tramadol non-medical use in Four European countries: A comparative analysis. Drug Alcohol Depend. 2020 12 01; 217:108367.
Score: 0.361
-
Iwanicki JL, Severtson SG, Margolin Z, Dasgupta N, Green JL, Dart RC. Consistency Between Opioid-Related Mortality Trends Derived From Poison Center and National Vital Statistics System, United States, 2006-2016. Am J Public Health. 2018 12; 108(12):1639-1645.
Score: 0.316
-
Iwanicki JL, Severtson SG, McDaniel H, Rosenblum A, Fong C, Cicero TJ, Ellis MS, Kurtz SP, Buttram ME, Dart RC. Abuse and Diversion of Immediate Release Opioid Analgesics as Compared to Extended Release Formulations in the United States. PLoS One. 2016; 11(12):e0167499.
Score: 0.276
-
Severtson SG, Haanschoten EE, Iwanicki J, Dart RC. Differences in severity of poison centers exposures involving XTAMPZA® ER versus other opioid analgesics. Pain Manag. 2023 Sep; 13(9):519-527.
Score: 0.111
-
Rockhill KM, Olson R, Dart RC, Iwanicki JL, Black JC. Differing Behaviors Around Adult Nonmedical Use of Prescription Stimulants and Opioids: Latent Class Analysis. J Med Internet Res. 2023 09 20; 25:e46742.
Score: 0.110
-
Severtson SG, Gurrola MC, Parrino MW, Ellis MS, Cicero TJ, Iwanicki JL, Dart RC. Abuse of tapentadol compared to other atypical opioids among individuals entering treatment for opioid use disorders. J Opioid Manag. 2023 Sep-Oct; 19(5):445-453.
Score: 0.110
-
Jewell J, Black J, Ellis M, Olsen H, Iwanicki J, Dart R. A Cross-Sectional Study of Tampering in Xtampza ER, an Abuse-Deterrent Formulation of an Extended-Release Opioid, in a Treatment Center Population. Clin Drug Investig. 2023 Mar; 43(3):197-203.
Score: 0.106
-
Dart RC, Iwanicki JL, Black JC, Olsen HA, Severtson SG. Measuring prescription opioid misuse and its consequences. Br J Clin Pharmacol. 2021 04; 87(4):1647-1653.
Score: 0.093
-
Geoffrey Severtson S, Kreider SED, Amioka EC, Margolin ZR, Iwanicki JL, Dart RC. Postmarketing Analysis of Misuse, Abuse, and Diversion of Xtampza ER. Pain Med. 2020 12 25; 21(12):3660-3668.
Score: 0.091
-
Dart RC, Iwanicki JL, Dasgupta N, Cicero TJ, Schnoll SH. Do abuse deterrent opioid formulations work? J Opioid Manag. 2017 Nov/Dec; 13(6):365-378.
Score: 0.073
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|